Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

collaboration

36 posts
RRoche
ChemoMetec enters collaboration agreement with Roche Diagnostics
Read More

ChemoMetec enters collaboration agreement with Roche Diagnostics

  • 2026-08-11
Chemometec A/S ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming…
RRoche
ChemoMetec enters collaboration agreement with Roche Diagnostics
Read More

ChemoMetec enters collaboration agreement with Roche Diagnostics

  • 2026-08-10
Chemometec A/S ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming…
RRoche
ChemoMetec enters collaboration agreement with Roche Diagnostics
Read More

ChemoMetec enters collaboration agreement with Roche Diagnostics

  • 2026-08-10
Chemometec A/S ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming…
RRoche
ChemoMetec enters collaboration agreement with Roche Diagnostics
Read More

ChemoMetec enters collaboration agreement with Roche Diagnostics

  • 2026-08-10
ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue…
LLausanne
10x Genomics, CHUV Partner on Single Cell Cancer Biomarker Study
Read More

10x Genomics, CHUV Partner on Single Cell Cancer Biomarker Study

  • 2026-08-04
10x Genomics and Lausanne University Hospital (CHUV) launched a research collaboration to advance diagnostic applications of single cell…
RRoche
Nurix-Roche Up to $2.3B Bexobrutideg Deal Closes
Read More

Nurix-Roche Up to $2.3B Bexobrutideg Deal Closes

  • 2026-07-22
Nurix Therapeutics (Nasdaq: NRIX) reported the closing of its previously announced global collaboration with Roche…
NNovartis
Health Headlines: Billion-Dollar Deals, Outbreaks, and Legal Victories
Read More

Health Headlines: Billion-Dollar Deals, Outbreaks, and Legal Victories

  • 2026-06-26
This week’s health news is marked by significant collaborative efforts and legal victories. Antares Therapeutics has secured a…
NNestlé
AI in food industry drives growth
Read More

AI in food industry drives growth

  • 2026-06-19
AI in food: summary AI in F&B boosts growth with predictive analytics to help forecast demand and reduce…
ZZürich
Zurich Insurance (Hong Kong) and YAS announce embedded insurance for robots
Read More

Zurich Insurance (Hong Kong) and YAS announce embedded insurance for robots

  • 2026-06-16
Driving AI and robotics adoption in Hong Kong with innovative InsurTech HONG KONG, June 16, 2026 /PRNewswire/ —…
AABB
ABB expands collaboration with NVIDIA through integration of DSX Blueprint for AI infrastructure
Read More

ABB expands collaboration with NVIDIA through integration of DSX Blueprint for AI infrastructure

  • 2026-06-10
ABB expands collaboration with NVIDIA Bringing SimReady™ 3D digital assets into NVIDIA Omniverse DSX Blueprint · GlobeNewswire Inc.…
RRoche
Nurix, Roche ink bexobrutideg BTK deal up to $2.3B
Read More

Nurix, Roche ink bexobrutideg BTK deal up to $2.3B

  • 2026-06-08
Nurix Therapeutics (Nasdaq: NRIX) announced a global collaboration with Roche to co-develop and…
RRoche
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
Read More

Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology

  • 2026-06-08
Agreement offers potential best-in-class targeted protein degrader therapy option for people living with B-cell malignanciesCollaboration adds to Roche’s…
Switzerland
www.europesays.com